{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:47:48Z","timestamp":1790646468391,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00415-011-6099-5","type":"journal-article","created":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T09:28:43Z","timestamp":1306315723000},"page":"2230-2239","source":"Crossref","is-referenced-by-count":76,"title":["Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington\u2019s disease provides in vivo evidence for impaired energy metabolism"],"prefix":"10.1007","volume":"258","author":[{"given":"Simon J. A.","family":"den Bogaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve M.","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter M.","family":"Teeuwisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermien E.","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymund A. C.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Grond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,26]]},"reference":[{"key":"6099_CR1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1212\/WNL.50.1.252","volume":"50","author":"EH Aylward","year":"1998","unstructured":"Aylward EH, Anderson NB, Bylsma FW, Wagster MV, Barta PE, Sherr M, Feeney J, Davis A, Rosenblatt A, Pearlson GD, Ross CA (1998) Frontal lobe volume in patients with Huntington\u2019s disease. Neurology 50:252\u2013258","journal-title":"Neurology"},{"key":"6099_CR2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","volume":"63","author":"EH Aylward","year":"2004","unstructured":"Aylward EH, Sparks BF, Field KM, Yallapragada V, Shpritz BD, Rosenblatt A, Brandt J, Gourley LM, Liang K, Zhou H, Margolis RL, Ross CA (2004) Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63:66\u201372","journal-title":"Neurology"},{"key":"6099_CR3","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2008-2543","volume":"94","author":"NA Aziz","year":"2009","unstructured":"Aziz NA, Pijl H, Frolich M, van der Graaf AW, Roelfsema F, Roos RA (2009) Increased hypothalamic-pituitary-adrenal axis activity in Huntington\u2019s disease. J Clin Endocrinol Metab 94:1223\u20131228","journal-title":"J Clin Endocrinol Metab"},{"key":"6099_CR4","volume-title":"BDI-II, Beck Depression Inventory: Manual","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Brown GK (1996) BDI-II, Beck Depression Inventory: Manual, 2nd edn. Harcourt Brace, San Antonio","edition":"2"},{"issue":"1","key":"6099_CR5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainresrev.2008.04.001","volume":"58","author":"I Bohanna","year":"2008","unstructured":"Bohanna I, Georgiou-Karistianis N, Hannan AJ, Egan GF (2008) Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington\u2019s disease. Brain Res Rev 58(1):209\u2013225","journal-title":"Brain Res Rev"},{"key":"6099_CR6","doi-asserted-by":"crossref","unstructured":"Clarke CE, Lowry M, Quarrell OWJ (1998) No change in striatal glutamate in Huntington\u2019s disease measured by proton magnetic resonance spectroscopy. Parkinsonism Relat Disord 4(3):123\u2013127","DOI":"10.1016\/S1353-8020(98)00026-1"},{"key":"6099_CR7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(92)90925-Y","volume":"580","author":"DS Dunlop","year":"1992","unstructured":"Dunlop DS, Mc Hale DM, Lajtha A (1992) Decreased brain N-acetylaspartate in Huntington\u2019s disease. Brain Res 580:44\u201348","journal-title":"Brain Res"},{"key":"6099_CR8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.arcmed.2007.11.011","volume":"39","author":"AM Estrada Sanchez","year":"2008","unstructured":"Estrada Sanchez AM, Mejia-Toiber J, Massieu L (2008) Excitotoxic neuronal death and the pathogenesis of Huntington\u2019s disease. Arch Med Res 39:265\u2013276","journal-title":"Arch Med Res"},{"key":"6099_CR9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1212\/01.wnl.0000257090.01107.2f","volume":"68","author":"B Gomez-Anson","year":"2007","unstructured":"Gomez-Anson B, Alegret M, Munoz E, Sainz A, Monte GC, Tolosa E (2007) Decreased frontal choline and neuropsychological performance in preclinical Huntington disease. Neurology 68:906\u2013910","journal-title":"Neurology"},{"key":"6099_CR10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.wno.0000177307.21081.81","volume":"25","author":"SK Gujar","year":"2005","unstructured":"Gujar SK, Maheshwari S, Bjorkman-Burtscher I, Sundgren PC (2005) Magnetic resonance spectroscopy. J Neuroophthalmol 25:217\u2013226","journal-title":"J Neuroophthalmol"},{"key":"6099_CR11","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","volume":"43","author":"BG Jenkins","year":"1993","unstructured":"Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR (1993) Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy. Neurology 43:2689\u20132695","journal-title":"Neurology"},{"key":"6099_CR12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","volume":"50","author":"BG Jenkins","year":"1998","unstructured":"Jenkins BG, Rosas HD, Chen YC, Makabe T, Myers R, MacDonald M, Rosen BR, Beal MF, Koroshetz WJ (1998) 1H NMR spectroscopy studies of Huntington\u2019s disease: correlations with CAG repeat numbers. Neurology 50:1357\u20131365","journal-title":"Neurology"},{"key":"6099_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR (2004) A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin Genet 65:267\u2013277","journal-title":"Clin Genet"},{"key":"6099_CR14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/mrm.21961","volume":"61","author":"R Mekle","year":"2009","unstructured":"Mekle R, Mlynarik V, Gambarota G, Hergt M, Krueger G, Gruetter R (2009) MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn Reson Med 61:1279\u20131285","journal-title":"Magn Reson Med"},{"issue":"8","key":"6099_CR15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2007","unstructured":"Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, McDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M (2007) Detection of Huntington\u2019s disease decades before diagnosis: the predict HD study. J Neurol Neurosurg Psychiatry 79(8):874\u2013880","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6099_CR16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney Jr","year":"1997","unstructured":"Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann Neurol 41:689\u2013692","journal-title":"Ann Neurol"},{"key":"6099_CR17","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","volume":"316","author":"TV Perneger","year":"1998","unstructured":"Perneger TV (1998) What\u2019s wrong with Bonferroni adjustments. BMJ 316:1236\u20131238","journal-title":"BMJ"},{"key":"6099_CR18","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","volume":"131","author":"M Politis","year":"2008","unstructured":"Politis M, Pavese N, Tai YF, Tabrizi SJ, Barker RA, Piccini P (2008) Hypothalamic involvement in Huntington\u2019s disease: an in vivo PET study. Brain 131:2860\u20132869","journal-title":"Brain"},{"key":"6099_CR19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","volume":"30","author":"SW Provencher","year":"1993","unstructured":"Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672\u2013679","journal-title":"Magn Reson Med"},{"key":"6099_CR20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","volume":"14","author":"SW Provencher","year":"2001","unstructured":"Provencher SW (2001) Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 14:260\u2013264","journal-title":"NMR Biomed"},{"key":"6099_CR21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2004.10.030","volume":"1031","author":"NC Reynolds Jr","year":"2005","unstructured":"Reynolds NC Jr, Prost RW, Mark LP (2005) Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington\u2019s disease. Brain Res 1031:82\u201389","journal-title":"Brain Res"},{"key":"6099_CR22","volume-title":"Handbook of clinical neurology, extrapyramidal disorders","author":"RAC Roos","year":"1986","unstructured":"Roos RAC (1986) Neuropathology of Huntington\u2019s chorea. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of clinical neurology, extrapyramidal disorders. Elsevier Science Publishers, Amsterdam"},{"key":"6099_CR23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/WCO.0b013e328304b692","volume":"21","author":"E Roze","year":"2008","unstructured":"Roze E, Saudou F, Caboche J (2008) Pathophysiology of Huntington\u2019s disease: from huntingtin functions to potential treatments. Curr Opin Neurol 21:497\u2013503","journal-title":"Curr Opin Neurol"},{"key":"6099_CR24","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/mds.21601","volume":"22","author":"HH Ruocco","year":"2007","unstructured":"Ruocco HH, Lopes-Cendes I, Li LM, Cendes F (2007) Evidence of thalamic dysfunction in Huntington disease by proton magnetic resonance spectroscopy. Mov Disord 22:2052\u20132056","journal-title":"Mov Disord"},{"key":"6099_CR25","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1212\/WNL.53.4.806","volume":"53","author":"R Sanchez-Pernaute","year":"1999","unstructured":"Sanchez-Pernaute R, Garcia-Segura JM, del Barrio AA, Viano J, de Yebenes JG (1999) Clinical correlation of striatal 1H MRS changes in Huntington\u2019s disease. Neurology 53:806\u2013812","journal-title":"Neurology"},{"key":"6099_CR26","first-page":"15","volume":"22","author":"B Schmand","year":"1991","unstructured":"Schmand B, Bakker D, Saan R, Louman J (1991) The Dutch reading test for adults: a measure of premorbid intelligence level. Tijdschr Gerontol Geriatr 22:15\u201319","journal-title":"Tijdschr Gerontol Geriatr"},{"issue":"19","key":"6099_CR27","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","volume":"75","author":"A Sturrock","year":"2010","unstructured":"Sturrock A, Laule C, Decolongon J, Dar SR, Coleman AJ, Creighton S, Bechtel N, Reilmann R, Hayden MR, Tabrizi SJ, MacKay AL, Leavitt BR (2010) Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology 75(19):1702\u20131710","journal-title":"Neurology"},{"key":"6099_CR28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1212\/01.WNL.0000070186.97463.A7","volume":"61","author":"SJ Tabrizi","year":"2003","unstructured":"Tabrizi SJ, Blamire AM, Manners DN, Rajagopalan B, Styles P, Schapira AH, Warner TT (2003) Creatine therapy for Huntington\u2019s disease: clinical and MRS findings in a 1-year pilot study. Neurology 61:141\u2013142","journal-title":"Neurology"},{"issue":"9","key":"6099_CR29","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8(9):791\u2013801","journal-title":"Lancet Neurol"},{"issue":"9","key":"6099_CR30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8(9):791\u2013801","journal-title":"Lancet Neurol"},{"key":"6099_CR31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mds.870110209","volume":"11","author":"SD Taylor-Robinson","year":"1996","unstructured":"Taylor-Robinson SD, Weeks RA, Bryant DJ, Sargentoni J, Marcus CD, Harding AE, Brooks DJ (1996) Proton magnetic resonance spectroscopy in Huntington\u2019s disease: evidence in favour of the glutamate excitotoxic theory. Mov Disord 11:167\u2013173","journal-title":"Mov Disord"},{"key":"6099_CR32","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0140-6736(94)90280-1","volume":"343","author":"SD Taylor-Robinson","year":"1994","unstructured":"Taylor-Robinson SD, Weeks RA, Sargentoni J, Marcus CD, Bryant DJ, Harding AE, Brooks DJ (1994) Evidence for glutamate excitotoxicity in Huntington\u2019s disease with proton magnetic resonance spectroscopy. Lancet 343:1170","journal-title":"Lancet"},{"key":"6099_CR33","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/mrm.22086","volume":"62","author":"I Tkac","year":"2009","unstructured":"Tkac I, Oz G, Adriany G, Ugurbil K, Gruetter R (2009) In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T. Magn Reson Med 62:868\u2013879","journal-title":"Magn Reson Med"},{"issue":"3","key":"6099_CR34","first-page":"412","volume":"258","author":"SJ Bogaard van den","year":"2010","unstructured":"van den Bogaard SJ, Dumas EM, Acharya TP, Johnson H, Langbehn DR, Scahill RI, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA (2010) Early atrophy of pallidum and accumbens nucleus in Huntington\u2019s disease. J Neurol 258(3):412\u2013420","journal-title":"J Neurol"},{"key":"6099_CR35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.brainres.2007.05.082","volume":"1168","author":"JC Oostrom van","year":"2007","unstructured":"van Oostrom JC, Sijens PE, Roos RA, Leenders KL (2007) 1H magnetic resonance spectroscopy in preclinical Huntington disease. Brain Res 1168:67\u201371","journal-title":"Brain Res"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00415-011-6099-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T04:45:41Z","timestamp":1560228341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-6099-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,26]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["6099"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-6099-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,26]]}}}